Sarah James
Stock Analyst at Cantor Fitzgerald
(2.15)
# 2,592
Out of 4,829 analysts
279
Total ratings
32.56%
Success rate
-3.01%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterates: Neutral | $290 | $249.53 | +16.22% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $404.58 | +19.88% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $333.46 | +9.46% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $24.81 | +16.89% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $8.26 | +81.60% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $148.83 | +18.93% | 20 | Feb 13, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $353.70 | +14.50% | 19 | Jan 27, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $380.64 | +83.90% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $62.79 | +43.33% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $23.84 | +118.12% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $21.19 | -19.77% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $181.78 | +20.48% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $322.20 | +26.01% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $22.16 | +94.04% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $4.13 | +287.41% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $66.97 | -7.42% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.40 | +257.14% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.11 | +40.65% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $95.30 | +5.98% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $143.76 | -7.48% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $17.44 | +140.83% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.64 | +37.36% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $5.40 | -7.41% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $15.12 | +38.93% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $55.74 | -30.03% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $68.64 | +181.18% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.50 | - | 2 | Mar 1, 2017 |
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $249.53
Upside: +16.22%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $404.58
Upside: +19.88%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $333.46
Upside: +9.46%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $24.81
Upside: +16.89%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $8.26
Upside: +81.60%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $148.83
Upside: +18.93%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $353.70
Upside: +14.50%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $380.64
Upside: +83.90%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $62.79
Upside: +43.33%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $23.84
Upside: +118.12%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $21.19
Upside: -19.77%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $181.78
Upside: +20.48%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $322.20
Upside: +26.01%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $22.16
Upside: +94.04%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $4.13
Upside: +287.41%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $66.97
Upside: -7.42%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.40
Upside: +257.14%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.11
Upside: +40.65%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $95.30
Upside: +5.98%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $143.76
Upside: -7.48%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $17.44
Upside: +140.83%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.64
Upside: +37.36%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $5.40
Upside: -7.41%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $15.12
Upside: +38.93%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $55.74
Upside: -30.03%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $68.64
Upside: +181.18%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.50
Upside: -